Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cybin Inc
(NY:
CYBN
)
9.880
-0.460 (-4.45%)
Official Closing Price
Updated: 8:00 PM EDT, Sep 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cybin Inc
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
37
38
Next >
March Update: Psychedelic Compounds-Based Drug Stocks Index Went Down -19%
April 01, 2022
An update on the revisions that have been made to the Pure-Play Psychedelic Compounds-Based Drug Stocks Index with the increase in the minimum market capitalization required to be included in the...
Via
Talk Markets
Cybin Announces Additional Adelia Milestone Achievement
April 01, 2022
From
Cybin Inc.
Via
Business Wire
Field Trip Health, Revive Therapeutics Among Top Psychedelic Movers Of Today
March 31, 2022
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 3.38% at $0.27
Via
Benzinga
Cybin Subsidiary Achieves Milestone
March 25, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Cybin Planning Pilot Study Of CYB004
March 22, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Commencement of Kernel Flow(R) Feasibility Study, Marking Exciting Moment for Psychedelic Drug Development
March 31, 2022
Via
Investor Brand Network
Cybin Begins Study Using Kernel Flow Headsets To Measure Ketamine's Effects On The Brain
March 31, 2022
The first study visit to measurethe psychedelic effects of ketamine in the cerebral cortex blood flowis underway, ...
Via
Benzinga
Cybin Announces Initiation of Kernel Flow® Feasibility Study Measuring Psychedelic Effects on the Brain
March 31, 2022
From
Cybin Inc.
Via
Business Wire
Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today
March 30, 2022
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 4.22% at $0.46
Via
Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) Announces Milestone In CYB003 Program
March 30, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) Announces Milestone in CYB003 Program
March 30, 2022
Via
Investor Brand Network
Psychedelic Stock Gainers And Losers From March 29, 2022
March 29, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 9.05% at $5.42
Via
Benzinga
Cybin Completes In Vivo Preclinical Studies For Major Depressive Disorder
March 29, 2022
Cybin Inc.(NYSE: CYBN) announced that its in vivo preclinical studies evaluating the proprietary drug CYB003 are completed. ...
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Significant Milestone Toward Advancing CYB003 Program
March 29, 2022
Via
Investor Brand Network
New Research Reveals How Psychedelics Are Helping Combat Mental Illness
March 29, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – March 29, 2022 – Mental health cases are continuing to rise and are taking a serious toll on the healthcare system. Luckily,...
Via
FinancialNewsMedia
Cybin Announces Successful Completion of In Vivo Preclinical Studies for its Deuterated Psilocybin Analog CYB003 Supporting Advancement into Phase 1/2a Clinical Trial
March 29, 2022
From
Cybin Inc.
Via
Business Wire
Mindset Pharma, Small Pharma Among Top Psychedelic Movers Of Today
March 28, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 8.24% at $0.18
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 25, 2022
March 25, 2022
GAINERS: Allied (OTC:
Via
Benzinga
Cybin (NEO: CYBN) (NYSE American: CYBN) Subsidiary Achieves Milestone
March 25, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Subsidiary Achieves Milestone Outlined in Contribution Agreement
March 25, 2022
Via
Investor Brand Network
Cybin Announces Additional Adelia Milestone Achievement
March 25, 2022
From
Cybin Inc.
Via
Business Wire
Allied, Field Trip Health Among Top Psychedelic Movers Of Today
March 24, 2022
GAINERS: Allied (OTC:
Via
Benzinga
BioMedNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Commences Participant Recruitment in Feasibility Study Using Kernel Flow Technology
March 24, 2022
Via
Investor Brand Network
Five Companies Developing Second Generation Psychedelics For Mental Health
March 24, 2022
Along with the psychedelic renaissance came a new type of drug: second generation psychedelics. Developed from classic psychedelics ...
Via
Benzinga
Cybin-Sponsored Feasibility Study Using Kernel Flow Technology Currently Recruiting Participants
March 24, 2022
From
Cybin Inc.
Via
Business Wire
Psychedelic Stock Gainers And Losers From March 23, 2022
March 23, 2022
GAINERS: Compass Pathways (NASDAQ:
Via
Benzinga
Mindset Pharma, Compass Pathways Among Top Psychedelic Movers Of Today
March 22, 2022
GAINERS: Mind Medicine (NASDAQ:
Via
Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) Planning Pilot Study of CYB004
March 22, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Field Trip Health, Mindset Pharma Among Top Psychedelic Movers Of Today
March 21, 2022
GAINERS: Field Trip Health (NASDAQ:
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Planning Pilot Study of CYB004, Pursuing Multiple Opportunities to Secure, Support Patent Position for R&D
March 21, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
37
38
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.